Activation of extracellular signal-regulated kinases ERK1 and ERK2 induces Bcl-xL up-regulation via inhibition of caspase activities in erythropoietin signaling

Journal of Cellular Physiology

Volumn 195, Issue 2, 2003, Pages 290-297

  Mori, Masaki ^a   Uchida, Mie ^a   Watanabe, Tomoko ^a   Kirito, Keita ^a   Hatake, Kiyohiko ^b   Ozawa, Keiya ^a   Komatsu, Norio ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CASPASE; CASPASE 3; CASPASE INHIBITOR; ERYTHROPOIETIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN BCL XL;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ERYTHROID CELL; ERYTHROID PRECURSOR CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; BCL-X PROTEIN; CASPASES; CELLS, CULTURED; ENZYME INHIBITORS; ERYTHROID PROGENITOR CELLS; ERYTHROPOIESIS; ERYTHROPOIETIN; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; UP-REGULATION;

EID: 0037401765     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10245     Document Type: Article

References (25)

1. Clem RJ, Cheng EH, Karp CL, Kirsch DG, Ueno K, Takahashi A, Kastan MB, Griffin DE, Earnshaw WC, Veliuona MA, Hardwick JM. 1998. Modulation of cell death by Bcl-xL through caspase interaction. Proc Natl Acad Sci USA 95:554-559.
2. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. 1998. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391:43-50.
3. Gregoli PA, Bondurant M. 1997. The roles of Bcl-xL and apopain in the control of erythropoiesis by erythropoietin. Blood 90:630-640.
4. Gregoli PA, Bondurant MC. 1998. Function of caspases in regulating apoptosis caused by erythropoietin deprivation in erythroid progenitors. J Cell Physiol 178:133-143.
5. Gregory T, Yu C, Ma A, Orkin SH, Blobel GA, Weiss MJ. 1999. GATA-1 and erythropoietin cooperate to promote erythroid cell survival by regulating bcl-xL expression. Blood 94:87-96.
6. Gross A, McDonnell JM, Korsmeyer SJ. 1999. BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13:1899-1911.
7. Ihle JN, Quelle FW, Miura O. 1993. Signal transduction through the receptor for erythropoietin. Semin Immunol 5:375-389.
8. Jacobs-Helber SM, Ryan JJ, Sawyer ST. 2000. JNK and p38 are activated by erythropoietin (EPO) but are not induced in apoptosis following EPO withdrawal in EPO-dependent HCD57 cells. Blood 96:933-940.
9. Kashii Y, Uchida M, Kirito K, Tanaka M, Nishijima K, Toshima M, Ando T, Koizumi K, Endoh T, Sawada K, Momoi M, Miura Y, Ozawa K, Komatsu N. 2000. A member of Forkhead family transcription factor, FKHRL1, is one of the downstream molecules of phosphatidylinositol 3-kinase-Akt activation pathway in erythropoietin signal transduction. Blood 96:941-949.
10. Komatsu N, Yamamoto M, Fujita H, Miwa A, Hatake K, Endo T, Okano H, Katsube T, Fukumaki Y, Sassa S, Miura Y. 1993. Establishment and characterization of an erythropoietin-dependent subline, UT-7/Epo, derived from human leukemia cell line, UT-7. Blood 82:456-464.
11. Koury MJ, Bondurant MC. 1988. Maintenance by erythropoietin of viability and maturation of murine erythroid precursor cells. J Cell Physiol 137:65-74.
12. Koury MJ, Bondurant MC. 1990. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 248:378-381.
13. Miura Y, Miura O, Ihle JN, Aoki N. 1994. Activation of the mitogen-activated protein kinase pathway by the erythropoietin receptor. J Biol Chem 269:29962-29969.
14. Nagata Y, Todokoro K. 1999. Requirement of activation of JNK and p38 for environmental stress-induced erythroid differentiation and apoptosis and of inhibition of ERK for apoptosis. Blood 94:853-863.
15. Negoro S, Oh H, Tone E, Kunisada K, Fujio Y, Walsh K, Kishimoto T, Yamauchi-Takihara K. 2001. Glycoprotein 130 regulates cardiac myocyte survival in doxorubicin-induced apoptosis through phosphatidylinositol 3-kinase/Akt phosphorylation and Bcl-xL/caspase-3 interaction. Circulation 103:555-561.
16. Nishida E, Gotoh Y. 1993. The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem Sci 18:128-131.
17. Sakahira H, Enari M, Nagata S. 1999. Functional differences of two forms of the inhibitor of caspase-activated DNase, ICAD-L, and ICAD-S. J Biol Chem 274:15740-15744.
18. Schimmer AD, Hedley DW, Penn LZ, Minden MD. 2001. Receptor- and mitochondrial-mediated apoptosis in acute leukemia: A translational view. Blood 98:3541-3553.
19. Seger R, Krebs EG. 1995. The MAPK signaling cascade. FASEB J 9:726-735.
20. Shan R, Price JO, Gaarde WA, Monia BP, Krantz SB, Zhao ZJ. 1999. Distinct roles of JNKs/p38 MAP kinase and ERKs in apoptosis and survival of HCD-57 cells induced by withdrawal of addition of erythropoietin. Blood 94:4067-4076.
21. Shi Y. 2002. Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell 9:459-470.
22. Silva M, Richard C, Benito A, Sanz C, Olalla I, Fernandez-Luna JL. 1998. Expression of Bcl-xL in erythroid precursors from patients with polycythemia vera. N Engl J Med 338:564-571.
23. Silva M, Benito A, Sanz C, Prosper F, Ekhterae D, Nunez G, Fernandez-Luna JL. 1999. Erythropoietin can induce the expression of bcl-xL through Stat5 in erythropoietin-dependent progenitor cell lines. J Biol Chem 274:22165-22169.
24. -/- mice due to decreased survival of early erythroblasts. Blood 98:3261-3273.
25. Uchida M, Kirito K, Shimizu R, Miura Y, Ozawa K, Komatsu N. 2001. A functional role of mitogen-activated protein kinases, erk1 and erk2, in the differentiation of a human leukemia cell line, UT-7/GM: A possible key factor for cell fate determination toward erythroid and megakaryocytic lineages. Int J Hematol 73:78-83.